These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 21472283)

  • 1. Imprinted tumor suppressor gene ARHI induces apoptosis correlated with changes in DNA methylation in pancreatic cancer cells.
    Yang H; Lu X; Qian J; Xu F; Hu Y; Yu Y; Bast RC; Li J
    Mol Med Rep; 2010; 3(4):581-7. PubMed ID: 21472283
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aberrant methylation and silencing of ARHI, an imprinted tumor suppressor gene in which the function is lost in breast cancers.
    Yuan J; Luo RZ; Fujii S; Wang L; Hu W; Andreeff M; Pan Y; Kadota M; Oshimura M; Sahin AA; Issa JP; Bast RC; Yu Y
    Cancer Res; 2003 Jul; 63(14):4174-80. PubMed ID: 12874023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Imprinted tumor suppressor genes ARHI and PEG3 are the most frequently down-regulated in human ovarian cancers by loss of heterozygosity and promoter methylation.
    Feng W; Marquez RT; Lu Z; Liu J; Lu KH; Issa JP; Fishman DM; Yu Y; Bast RC
    Cancer; 2008 Apr; 112(7):1489-502. PubMed ID: 18286529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Re-expression of ARHI (DIRAS3) induces autophagy in breast cancer cells and enhances the inhibitory effect of paclitaxel.
    Zou CF; Jia L; Jin H; Yao M; Zhao N; Huan J; Lu Z; Bast RC; Feng Y; Yu Y
    BMC Cancer; 2011 Jan; 11():22. PubMed ID: 21244707
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biochemistry and biology of ARHI (DIRAS3), an imprinted tumor suppressor gene whose expression is lost in ovarian and breast cancers.
    Yu Y; Luo R; Lu Z; Wei Feng W; Badgwell D; Issa JP; Rosen DG; Liu J; Bast RC
    Methods Enzymol; 2006; 407():455-68. PubMed ID: 16757345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Role of Methylation in the CpG Island of the ARHI Promoter Region in Cancers.
    Liu X; Zhang T; Li Y; Zhang Y; Zhang H; Wang X; Li L
    Adv Exp Med Biol; 2020; 1255():123-132. PubMed ID: 32949395
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigenetic regulation of ARHI in breast and ovarian cancer cells.
    Yu Y; Fujii S; Yuan J; Luo RZ; Wang L; Bao J; Kadota M; Oshimura M; Dent SR; Issa JP; Bast RC
    Ann N Y Acad Sci; 2003 Mar; 983():268-77. PubMed ID: 12724231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decitabine and suberoylanilide hydroxamic acid (SAHA) inhibit growth of ovarian cancer cell lines and xenografts while inducing expression of imprinted tumor suppressor genes, apoptosis, G2/M arrest, and autophagy.
    Chen MY; Liao WS; Lu Z; Bornmann WG; Hennessey V; Washington MN; Rosner GL; Yu Y; Ahmed AA; Bast RC
    Cancer; 2011 Oct; 117(19):4424-38. PubMed ID: 21491416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reexpression of the tumor suppressor gene ARHI induces apoptosis in ovarian and breast cancer cells through a caspase-independent calpain-dependent pathway.
    Bao JJ; Le XF; Wang RY; Yuan J; Wang L; Atkinson EN; LaPushin R; Andreeff M; Fang B; Yu Y; Bast RC
    Cancer Res; 2002 Dec; 62(24):7264-72. PubMed ID: 12499268
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The tumor suppressor gene ARHI regulates autophagy and tumor dormancy in human ovarian cancer cells.
    Lu Z; Luo RZ; Lu Y; Zhang X; Yu Q; Khare S; Kondo S; Kondo Y; Yu Y; Mills GB; Liao WS; Bast RC
    J Clin Invest; 2008 Dec; 118(12):3917-29. PubMed ID: 19033662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression and epigenetic regulation of angiogenesis-related factors during dormancy and recurrent growth of ovarian carcinoma.
    Lyu T; Jia N; Wang J; Yan X; Yu Y; Lu Z; Bast RC; Hua K; Feng W
    Epigenetics; 2013 Dec; 8(12):1330-46. PubMed ID: 24135786
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ARHI (DIRAS3)-mediated autophagy-associated cell death enhances chemosensitivity to cisplatin in ovarian cancer cell lines and xenografts.
    Washington MN; Suh G; Orozco AF; Sutton MN; Yang H; Wang Y; Mao W; Millward S; Ornelas A; Atkinson N; Liao W; Bast RC; Lu Z
    Cell Death Dis; 2015 Aug; 6(8):e1836. PubMed ID: 26247722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of the tumor suppressor ARHI inhibits the growth of pancreatic cancer cells by inducing G1 cell cycle arrest.
    Lu X; Qian J; Yu Y; Yang H; Li J
    Oncol Rep; 2009 Sep; 22(3):635-40. PubMed ID: 19639215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. STAT3 acetylation-induced promoter methylation is associated with downregulation of the ARHI tumor-suppressor gene in ovarian cancer.
    Li J; Cui G; Sun L; Wang SJ; Li YL; Meng YG; Guan Z; Fan WS; Li LA; Yang YZ; You YQ; Fu XY; Yan ZF; Huang K
    Oncol Rep; 2013 Jul; 30(1):165-70. PubMed ID: 23604529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reactivation of the silenced and imprinted alleles of ARHI is associated with increased histone H3 acetylation and decreased histone H3 lysine 9 methylation.
    Fujii S; Luo RZ; Yuan J; Kadota M; Oshimura M; Dent SR; Kondo Y; Issa JP; Bast RC; Yu Y
    Hum Mol Genet; 2003 Aug; 12(15):1791-800. PubMed ID: 12874100
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of the expression of the tumor suppressor gene ARHI is associated with progression of breast cancer.
    Wang L; Hoque A; Luo RZ; Yuan J; Lu Z; Nishimoto A; Liu J; Sahin AA; Lippman SM; Bast RC; Yu Y
    Clin Cancer Res; 2003 Sep; 9(10 Pt 1):3660-6. PubMed ID: 14506155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcriptional and posttranscriptional down-regulation of the imprinted tumor suppressor gene ARHI (DRAS3) in ovarian cancer.
    Lu Z; Luo RZ; Peng H; Rosen DG; Atkinson EN; Warneke C; Huang M; Nishmoto A; Liu J; Liao WS; Yu Y; Bast RC
    Clin Cancer Res; 2006 Apr; 12(8):2404-13. PubMed ID: 16638845
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Ras homologue member I directly inhibits signal transducers and activators of transcription 3 translocation and activity in human breast and ovarian cancer cells.
    Nishimoto A; Yu Y; Lu Z; Mao X; Ren Z; Watowich SS; Mills GB; Liao WS; Chen X; Bast RC; Luo RZ
    Cancer Res; 2005 Aug; 65(15):6701-10. PubMed ID: 16061651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitory effect of ARHI on pancreatic cancer cells and NF-κB activity.
    Hu YQ; Si LJ; Ye ZS; Lin ZH; Zhou JP
    Mol Med Rep; 2013 Apr; 7(4):1180-4. PubMed ID: 23447002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of the tumor suppressor gene ARHI in epithelial ovarian cancer is associated with increased expression of p21WAF1/CIP1 and prolonged progression-free survival.
    Rosen DG; Wang L; Jain AN; Lu KH; Luo RZ; Yu Y; Liu J; Bast RC
    Clin Cancer Res; 2004 Oct; 10(19):6559-66. PubMed ID: 15475444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.